John Kappos, a registered patent attorney for over 20 years, was lead or co-lead counsel in patent litigations in federal district courts throughout the nation, in the International Trade Commission, and in domestic and international arbitrations. John has also assisted companies in post grant review proceedings, inter partes review proceedings, and Board of Patent Appeals and Interferences proceedings.
Honors & Awards
- “Life Sciences Star” for General Patent Litigation by LMG Life Sciences (2018-2020)
- Repeatedly recognized as a Southern California “Super Lawyer” in a survey conducted by Law & Politics Media Inc. and published in Los Angeles magazine and the Southern California edition of Super Lawyers
- Named a “Rising Star” by the same organization
Admissions
Bar Admissions
Court Admissions
- US District Court, Southern, Northern, Eastern, and Central Districts of California
- US Court of Appeals, Second, Ninth, and Federal Circuits
- US Supreme Court
Registered to Practice
- US Patent & Trademark Office
Education
- University of California at Los Angeles, J.D., 1994
- Harvard University, Ph.D., Chemistry, 1991
- University of California at Irvine, B.S., Chemistry, 1986
Professional Activities
Member
- American Intellectual Property Law Association
- American Bar Association
- Los Angeles Intellectual Property Law Association
- Orange County Patent Law Association
- Federal Circuit Bar Association
- Orange County Bar Association
Speaker
- “Is The Supreme Court Exhausted With Patents?," O’Melveny Corporate Counsel Seminar (July 2008)
- “Complying With The Duty Of Care And Avoiding Willful Patent Infringement," O’Melveny Corporate Counsel Seminar (August 2006)
Co-Author
- “Patent Venue Reform: Forum Shopping In A Bear Market,” The Recorder (December 2020)
- “Supreme Court Back in the Patent Limelight,” Orange County Business Journal (August 2014)
- “Medical Treatment and Diagnostic Procedures - Patent Eligible?,” Orange County Business Journal (August 2010)
- “Changing Opinions on Willful Patent Infringement,” Orange County Business Journal (August 2009)
- “Redefining Obviousness After KSR Decision: Eisai Provides Some Greatly Needed Predictability for Biotech and Pharma,” Genetic Engineering & Biotechnology News (October 2008)
- “Is the Supreme Court Exhausted With Patents?” Orange County Business Journal (September 2008)